Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan
· Delayed Price · Currency is TWD 36.00
-0.15 (-0.41%)
Mar 9, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 1.65 billion as of March 9, 2026. Its market cap has decreased by -8.05% in one year.
Market Cap
1.65B
Enterprise Value
2.08B
Revenue
467.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
Market Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 1.65B, an increase of 114.58%. That is a compound annual growth rate of 3.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.64B |
| GeneFerm Biotechnology | 1.72B |
| Winston Medical Supply | 1.48B |
| TSH Biopharm Corporation | 1.99B |
| DV Biomed | 1.34B |
| Excelsior Biopharma | 1.26B |
| Golden Biotechnology | 2.26B |
| Anxo Pharmaceutical | 1.13B |